UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 210

Sortiert nach

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

Thyroid (New York, N.Y.), 2015-06, Vol.25 (6), p.567

2015

Volltextzugriff (PDF)

Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon‐specific penetrance and changes in management during the last four decades

Clinical endocrinology (Oxford), 2017-10, Vol.87 (4), p.320-326

2017

Volltextzugriff (PDF)

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series

Clinical endocrinology (Oxford), 2022-06, Vol.96 (6), p.847-856

2022

Volltextzugriff (PDF)

Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC

Molecular and cellular endocrinology, 2010-06, Vol.322 (1), p.2-7

2010

Volltextzugriff (PDF)

Genotype-phenotype correlation in multiple endocrine neoplasia type 2

Clinics (São Paulo, Brazil), 2012-01, Vol.67 (suppl 1), p.69-75

2012

Volltextzugriff (PDF)

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

The New England journal of medicine, 2003-10, Vol.349 (16), p.1517-1525

2003

Volltextzugriff (PDF)

Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease

Hormone and metabolic research, 2016-12, Vol.48 (12), p.806

2016

Volltextzugriff (PDF)

Thyroid dysfunction in peri- and postmenopausal women—cumulative risks

Deutsches Ärzteblatt international, 2023-05

2023

Volltextzugriff (PDF)

Thyroid Cancer: Risk-Stratified Management and Individualized Therapy

Clinical cancer research, 2016-10, Vol.22 (20), p.5012-5021

2016

Volltextzugriff (PDF)

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

European journal of endocrinology, 2006-08, Vol.155 (2), p.229

2006

Volltextzugriff (PDF)

Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia

PloS one, 2014-12, Vol.9 (12), p.e115178-e115178

2014

Volltextzugriff (PDF)

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer

Clinical endocrinology (Oxford), 2012-05, Vol.76 (5), p.691-697

2012

Volltextzugriff (PDF)

Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management

Hormones (Athens, Greece), 2009-01, Vol.8 (1), p.23-28

2009

Volltextzugriff (PDF)

Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey

Clinical endocrinology (Oxford), 2011-12, Vol.75 (6), p.760-765

2011

Volltextzugriff (PDF)

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis

Cancers, 2022-07, Vol.14 (14), p.3405

2022

Volltextzugriff (PDF)

Schilddrüse und Schwangerschaft

Geburtshilfe und Frauenheilkunde, 2021-07, Vol.81 (7), p.745-748

Frank-Raue, Karin

2021

Volltextzugriff (PDF)

Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers

Clinical endocrinology (Oxford), 2007-10, Vol.67 (4), p.613-622

2007

Volltextzugriff (PDF)

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

Human mutation, 2011-01, Vol.32 (1), p.51-58

2011

Volltextzugriff (PDF)

Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism

Clinical endocrinology (Oxford), 2011-07, Vol.75 (1), p.50-55

2011

Volltextzugriff (PDF)

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791

Clinical endocrinology (Oxford), 2008-08, Vol.69 (2), p.259-263

2008

Volltextzugriff (PDF)

Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma

The journal of clinical endocrinology and metabolism, 2021-09, Vol.106 (9), p.e3582-e3591

2021

Volltextzugriff (PDF)

CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum

European journal of endocrinology, 2011-09, Vol.165 (3), p.477

2011

Volltextzugriff (PDF)

Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors

The journal of clinical endocrinology and metabolism, 2008-12, Vol.93 (12), p.4797-4803

2008

Volltextzugriff (PDF)

2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer

European thyroid journal, 2013-01, Vol.1 (4), p.216-231

2013

Volltextzugriff (PDF)

Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center

The journal of clinical endocrinology and metabolism, 2019-10, Vol.104 (10), p.4264-4272

2019

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Humans
(93)
Life Sciences & Biomedicine
(90)
Female
(57)
Male
(55)
Endocrinology & Metabolism
(52)
Adult
(48)
Middle Aged
(38)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Thyroid Neoplasms - Genetics
(32)
Adolescent
(28)
Aged
(27)
Endocrinopathies
(27)
Mutation
(26)
Multiple Endocrine Neoplasia Type 2a - Genetics
(25)
Proto-Oncogene Proteins C-Ret - Genetics
(22)
Carcinoma, Medullary - Genetics
(21)
Thyroid Neoplasms - Pathology
(21)
Calcitonin - Blood
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma

Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon‐specific penetrance and changes in management during the last four decades

Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series

Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC

Genotype-phenotype correlation in multiple endocrine neoplasia type 2

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial Disease

Thyroid dysfunction in peri- and postmenopausal women—cumulative risks

Thyroid Cancer: Risk-Stratified Management and Individualized Therapy

Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype

Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer

Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management

Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey

Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors—A Retrospective Multi-Center Registry Analysis

Schilddrüse und Schwangerschaft

Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers

Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism

Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791

Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma

CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum

Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors

2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer

Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center

Suchergebnisse filtern